Robin Fåhræus

9.9k total citations
136 papers, 5.7k citations indexed

About

Robin Fåhræus is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Robin Fåhræus has authored 136 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Molecular Biology, 78 papers in Oncology and 28 papers in Immunology. Recurrent topics in Robin Fåhræus's work include Cancer-related Molecular Pathways (45 papers), RNA modifications and cancer (26 papers) and Ubiquitin and proteasome pathways (24 papers). Robin Fåhræus is often cited by papers focused on Cancer-related Molecular Pathways (45 papers), RNA modifications and cancer (26 papers) and Ubiquitin and proteasome pathways (24 papers). Robin Fåhræus collaborates with scholars based in France, Sweden and Czechia. Robin Fåhræus's co-authors include Yili Yin, Bénédicte Manoury, Chrysoula Daskalogianni, Vanesa Olivares‐Illana, David P. Lane, Marco M. Candeias, Lars Rymo, Sébastien Apcher, George Klein and Laurence Malbert-Colas and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Robin Fåhræus

131 papers receiving 5.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robin Fåhræus France 44 3.1k 2.9k 1.0k 745 632 136 5.7k
Sai Wah Tsao Hong Kong 44 2.4k 0.8× 2.1k 0.7× 768 0.7× 485 0.7× 1.1k 1.8× 96 4.8k
László Székely Sweden 41 2.3k 0.7× 2.5k 0.9× 848 0.8× 741 1.0× 388 0.6× 146 5.7k
Preet M. Chaudhary United States 42 3.4k 1.1× 2.8k 0.9× 1.9k 1.9× 476 0.6× 1.2k 1.8× 88 6.4k
Wolfgang Sommergruber Austria 38 2.7k 0.9× 1.5k 0.5× 699 0.7× 301 0.4× 723 1.1× 78 5.3k
Enrique A. Mesri United States 30 1.7k 0.6× 3.1k 1.1× 1.3k 1.2× 930 1.2× 549 0.9× 60 5.5k
Jamie I. Fletcher Australia 28 5.1k 1.6× 2.0k 0.7× 1.0k 1.0× 388 0.5× 912 1.4× 63 7.1k
Jules P.P. Meijerink Netherlands 48 3.9k 1.2× 1.5k 0.5× 1.3k 1.3× 783 1.1× 700 1.1× 132 7.4k
Jeffrey J. Babon Australia 38 2.7k 0.9× 1.8k 0.6× 2.0k 2.0× 299 0.4× 496 0.8× 96 5.6k
Emmett V. Schmidt United States 51 4.6k 1.5× 3.7k 1.3× 1.7k 1.6× 537 0.7× 1.2k 1.8× 144 9.3k
Wenbin Wei United Kingdom 40 2.3k 0.7× 1.5k 0.5× 767 0.7× 678 0.9× 714 1.1× 134 4.5k

Countries citing papers authored by Robin Fåhræus

Since Specialization
Citations

This map shows the geographic impact of Robin Fåhræus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Fåhræus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Fåhræus more than expected).

Fields of papers citing papers by Robin Fåhræus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin Fåhræus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Fåhræus. The network helps show where Robin Fåhræus may publish in the future.

Co-authorship network of co-authors of Robin Fåhræus

This figure shows the co-authorship network connecting the top 25 collaborators of Robin Fåhræus. A scholar is included among the top collaborators of Robin Fåhræus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin Fåhræus. Robin Fåhræus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Sa, Lixiao Wang, Laurence Malbert-Colas, et al.. (2025). The p53 mRNA exhibits riboswitch-like features under DNA damage conditions. iScience. 28(10). 113555–113555.
2.
López, Ignacio, et al.. (2024). Re-appraising the evidence for the source, regulation and function of p53-family isoforms. Nucleic Acids Research. 52(20). 12112–12129. 5 indexed citations
3.
Pla, Marika, Chrysoula Daskalogianni, Rodrigo Prado Martins, et al.. (2023). Major histocompatibility class I antigenic peptides derived from translation of pre-mRNAs generate immune tolerance. Proceedings of the National Academy of Sciences. 120(7). e2208509120–e2208509120. 4 indexed citations
4.
Daskalogianni, Chrysoula, et al.. (2021). Targeting Viral mRNA Translation Control as a New Concept for Anti-Virus Therapeutic Strategies. 2(2). 1 indexed citations
5.
Malbert-Colas, Laurence, Chrysoula Daskalogianni, Anton Granzhan, et al.. (2021). The different activities of RNA G-quadruplex structures are controlled by flanking sequences. Life Science Alliance. 5(2). e202101232–e202101232. 14 indexed citations
6.
Kalathiya, Umesh, Monikaben Padariya, Robin Fåhræus, Soumyananda Chakraborti, & Ted R. Hupp. (2021). Multivalent Display of SARS-CoV-2 Spike (RBD Domain) of COVID-19 to Nanomaterial, Protein Ferritin Nanocages. Biomolecules. 11(2). 297–297. 23 indexed citations
7.
Boldrup, Linda, Philip J. Coates, Xiaolian Gu, et al.. (2021). Low potential of circulating interleukin 1 receptor antagonist as a prediction marker for squamous cell carcinoma of the head and neck. Journal of Oral Pathology and Medicine. 50(8). 785–794. 6 indexed citations
8.
Apcher, Sébastien, et al.. (2021). mRNA translation from an antigen presentation perspective: A tribute to the works of Nilabh Shastri. Molecular Immunology. 141. 305–308. 3 indexed citations
9.
Wilms, Torben, Xiaolian Gu, Linda Boldrup, et al.. (2020). PD‐L1 in squamous cell carcinoma of the oral tongue shows gender‐specific association with prognosis. Oral Diseases. 26(7). 1414–1423. 9 indexed citations
10.
Martins, Rodrigo Prado, et al.. (2018). In Cellulo Protein-mRNA Interaction Assay to Determine the Action of G-Quadruplex-Binding Molecules. Molecules. 23(12). 3124–3124. 19 indexed citations
11.
Jain, Saurabh, Luca Aresu, S. Comazzi, et al.. (2016). The Development of a Recombinant scFv Monoclonal Antibody Targeting Canine CD20 for Use in Comparative Medicine. PLoS ONE. 11(2). e0148366–e0148366. 78 indexed citations
12.
López, Ignacio, et al.. (2015). The alternative translated MDMXp60isoform regulates MDM2 activity. Cell Cycle. 14(3). 449–458. 8 indexed citations
13.
Gu, Xiaolian, Elisabet Nylander, Philip J. Coates, Robin Fåhræus, & Karin Nylander. (2015). Correlation between Reversal of DNA Methylation and Clinical Symptoms in Psoriatic Epidermis Following Narrow-Band UVB Phototherapy. Journal of Investigative Dermatology. 135(8). 2077–2083. 48 indexed citations
14.
Fåhræus, Robin, Peter M. Fischer, Eberhard Krausz, & David P. Lane. (1999). New approaches to cancer therapies. The Journal of Pathology. 187(1). 138–146. 19 indexed citations
15.
Fåhræus, Robin, Peter Fischer, Eberhard Krausz, & David P. Lane. (1999). New approaches to cancer therapies. The Journal of Pathology. 187(1). 138–146. 1 indexed citations
17.
Ball, Kathryn L., Sonia Laı́n, Robin Fåhræus, Carl Smythe, & David P. Lane. (1997). Cell-cycle arrest and inhibition of Cdk4 activity by small peptides based on the carboxy-terminal domain of p21WAF1. Current Biology. 7(1). 71–80. 127 indexed citations
18.
Fåhræus, Robin, Ingemar Ernberg, Jürgen Finke, et al.. (1988). Expression of Epstein‐Barr virus‐encoded proteins in nasopharyngeal carcinoma. International Journal of Cancer. 42(3). 329–338. 388 indexed citations
19.
Ricksten, Anne, Bengt Kallin, Hannah Alexander, et al.. (1988). BamHI E region of the Epstein-Barr virus genome encodes three transformation-associated nuclear proteins.. Proceedings of the National Academy of Sciences. 85(4). 995–999. 58 indexed citations
20.
Fåhræus, Robin. (1963). The influence of the spleen on normal and pathologic cells in the blood. Journal of Cancer Research and Clinical Oncology. 65(6). 560–564. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026